Transcatheter Mitral Valve Dispute: CardiAQ Claims Neovasc Is Using Stolen Technology
This article was originally published in The Gray Sheet
Executive Summary
CardiAQ has filed a federal lawsuit in Boston seeking to enjoin Neovasc from further developing its transcatheter mitral valve platform, including the Tiara, because, CardiAQ claims, Neovasc illegally co-opted the technology from CardiAQ.